Navigation Links
WellPoint NextRx Announces New Agreement With Blue Cross of Idaho
Date:5/7/2008

THOUSAND OAKS, Calif., May 7 /PRNewswire-FirstCall/ -- WellPoint NextRx, the nation's largest health plan-owned pharmacy benefits manager (PBM) announced a new five-year agreement with Blue Cross of Idaho to serve as the pharmacy benefits manager for their 550,000 members. NextRx has served as PBM for Blue Cross of Idaho, an independent licensee of the Blue Cross Blue Shield Association, since 1997 and the renewal of this contract will extend this agreement for an additional five years.

Under this agreement, NextRx will continue to provide Blue Cross of Idaho with pharmacy benefits management services for their individual, group and Medicare Part D members. Under this agreement, Blue Cross of Idaho will utilize NextRx's fully integrated management systems to provide claims processing, network management mail services, and prior authorization services. WellPoint NextRx will also support the plan's clinical programs, drug utilization review and formulary management.

"Because of our health plan heritage, NextRx is able to work with our health plan clients to connect medical and pharmacy data to more effectively meet the needs of their members," said Renwyck Elder, president of WellPoint NextRx, a division of WellPoint, Inc. "We are pleased to continue our collaboration with Blue Cross of Idaho and help them develop programs that offer access to quality medications that are more affordable for their members."

Working collaboratively with Blue Cross of Idaho, NextRx has developed programs and initiatives that provide their members with access to quality medications while helping to manage their costs, such as the development of a generics program that allows members to try generics drugs for free for up to six months. In addition, NextRx has designed programs to educate customers who suffer from chronic conditions such as asthma or cardiovascular disease to ensure they are adhering to their medications to help them achieve improved results.

WellPoint NextRx is a service mark of WellPoint, Inc. Services are provided by a WellPoint PBM (either NextRx Services, Inc. or NextRx, LLC, as applicable). WellPoint NextRx is a division of WellPoint, Inc.

About WellPoint, Inc.:

WellPoint, Inc. is the largest health benefits company in terms of medical membership in the United States. WellPoint is an independent licensee of the Blue Cross and Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as Empire Blue Cross Blue Shield in 10 New York City metropolitan and surrounding counties and as Empire Blue Cross or Empire Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia (excluding the city of Fairfax, the town of Vienna and the area east of State Route 123.), Wisconsin; and through UniCare. Additional information about WellPoint is available at http://www.wellpoint.com .


'/>"/>
SOURCE WellPoint, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WellPoint Wins Medicare Administrative Contract Worth up to $323 Million
2. BlueCross BlueShield of South Carolina and WellPoint Affiliate Receive State Approval for Ten South Carolina Counties
3. WellPoint Announces Acquisition of DeCare Dental
4. WellPoint Foundation Supports National Campaign Focused on Depression Among Men
5. WellPoint Reports First Quarter 2008 Results
6. Shareholder Class Action Filed Against WellPoint, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
7. WellPoint Appoints Kevin R. Hayden as President of State Sponsored Business
8. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of WellPoint, Inc. Who Invested in the WellPoint Retirement Savings Plan
9. WellPoint to Hold Conference Call and Webcast to Discuss First Quarter Results On April 23, 2008
10. WellPoints Health Plans to Cover Newly Approved Cancer Treatment
11. WellPoint Announces Appearances at Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: